Abstract
Temozolomide (TMZ) is an antineoplastic alkylating agent with activity against serious and aggressive types of brain tumours. It has been postulated that TMZ exerts its antitumor activity via its spontaneous degradation at physiological pH. The in vitro evaluation of the interaction of TMZ and its final metabolites, 5-aminoimidazole-4-carboxamide (AIC) and methyldiazonium ion, with double-stranded DNA (dsDNA) was studied using differential pulse voltammetry at a glassy carbon electrode. The DNA damage was electrochemically detected following the changes in the oxidation peaks of guanosine and adenosine residues. The results obtained revealed the decrease of the dsDNA oxidation peaks with incubation time, showing that TMZ and AIC/methyldiazonium ion interact with dsDNA causing its condensation. Furthermore, the experiments of the in situ TMZ and AIC/methyldiazonium ion–dsDNA interaction using the multilayer dsDNA-electrochemical biosensor confirmed the condensation of dsDNA caused by these species and showed evidence for a specific interaction between the guanosine residues and TMZ metabolites, since free guanine oxidation peak was detected. The oxidative damage caused to DNA bases by TMZ metabolites was also detected electrochemically by monitoring the appearance of the 8-oxoguanine/2,8-dyhydroxyadenine oxidation peaks. Nondenaturing agarose gel electrophoresis of AIC/methyldiazonium ion–dsDNA samples confirmed the occurrence of dsDNA condensation and oxidative damage observed in the electrochemical results. The importance of the dsDNA-electrochemical biosensor in the in situ evaluation of TMZ–dsDNA interactions is clearly demonstrated.
Similar content being viewed by others
References
Marchesi F, Turriziani M, Tortorelli G, Avvisati G, Torino F, De Vecchis L (2007) Pharmacol Res 56:275–287
Chaney SG, Sancar A (1996) J Natl Cancer Inst 88:1346–1360
Stevens MF, Hickman JA, Stone R, Gibson NW, Baig GU, Lunt E, Newton CG (1984) J Med Chem 27:196–201
Darkes MJM, Plosker GL, Jarvis B (2002) Am J Cancer 1:55–80
Baker SD, Wirth M, Statkevich P, Reidenberg P, Alton K, Sartorius SE, Dugan M, Cutler D, Batra V, Grochow LB, Donehower RC, Rowinsky EK (1999) Clin Cancer Res 5:309–317
Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, Albright R, Olson J, Chang SM, O’Neill AM, Friedman AH, Bruner J, Yue N, Dugan M, Zaknoen S, Levin VA (1999) J Clin Oncol 17:2762–2771
Pacia A, Rieutorda A, Brion F, Prognon P (2001) J Chromatogr B 764:255–287
Chalmers AJ, Ruff EM, Martindale C, Lovegrove N, Short SC (2009) Int J Radiat Oncol 75:1511–1519
Kondo N, Takahashi A, Mori E, Ohnishi K, McKinnon PJ, Sakaki T, Nakase H, Ohnishi T (2009) Biochem Biophys Res Commun 387:656–660
Wang Y, Liu L, Wu C, Bulgar A, Somoza E, Zhu W, Gerson SL (2009) Nucl Med Biol 36:975–983
Cui B, Johnson SP, Bullock N, Ali-Osman F, Bigner DD, Friedman HS (2010) J Biomed Res 24:424–435
Britten CD, Rowinsky EK, Baker SD, Agarwala SS, Eckardt JR, Barrington R, Diab SG, Hammond LA, Johnson T, Villalona-Calero M, Fraass U, Statkevich P, Von Hoff DD, Eckhardt SG (1999) Clin Cancer Res 5:1629–1637
Park DM, Shah DD, Egorin MJ, Beumer JH (2009) J Neuro-Oncol 93:279–283
Kim H, Likhari P, Parker D, Statkevich P, Marco A, Lin CC, Nomeir AA (2001) J Pharm Biomed Anal 24:461–468
Andrasi M, Bustos R, Gaspar A, Gomez FA, Klekner A (2010) J Chromatogr B 878:1801–1808
Kim HK, Lin CC, Parker D, Veals J, Lim J, Likhari P, Statkevich P, Marco A, Nomeir AA (1997) J Chromatogr B 703:225–233
Diez BD, Statkevich P, Zhu Y, Abutarif MA, Xuan F, Kantesaria B, Cutler D, Cantillon M, Schwarz M, Pallotta MG, Ottaviano FH (2010) Cancer Chemother Pharmacol 65:727–734
Taverna P, Liu L, Hwang H-S, Hanson AJ, Kinsella TJ, Gerson SL (2001) Mutat Res 485:269–281
Passagne I, Evrard A, Depeille P, Cuq P, Cupissol D, Vian L (2006) Toxicol Appl Pharmacol 211:97–105
Jakubowicz-Gil J, Langner E, Wertel I, Piersiak T, Rzeski W (2010) Chem Biol Interact 188:190–203
Brett CMA, Oliveira-Brett AM (2003) In: Bard AJ, Stratmann M (eds) Encyclopedia of electrochemistry. Wiley-VCH, Weinheim
Oliveira SCB, Oliveira-Brett AM (2010) Comb Chem High Throuhput Screen 13:628–640
Pontinha AD, Jorge SM, Chiorcea-Paquim AM, Diculescu VC, Oliveira-Brett AM (2011) Phys Chem Chem Phys 13:5227–5234
Santos PVF, Lopes IC, Diculescu VC, Oliveira-Brett AM (2012) Electroanalysis 24:547–553
Chiorcea-Paquim AM, Corduneanu O, Oliveira SCB, Diculescu VC, Oliveira-Brett AM (2009) Electrochim Acta 54:1978–1985
Oliveira SCB, Oliveira-Brett AM (2010) Anal Bioanal Chem 398:1633–1641
Oliveira SCB, Oliveira-Brett AM (2012) Langmuir 28(10):4896–4901
Oliveira-Brett AM, da Silva LA, Brett CMA (2002) Langmuir 18:2326–2330
Goyal RN, Sangal A (2002) J Electroanal Chem 521:72–80
Ghalkhani M, Fernandes IPG, Oliveira SCB, Shahrokhian S, Oliveira-Brett AM (2010) Electroanalysis 22:2633–2640
Rodriguez JRB, Garcia AC, Ordieres AJM, Blanco PT (1989) Electroanalysis 1:529–534
Brody JR, Kern SE (2004) Anal Biochem 333:1–13
Piedade JAP, Oliveira PSC, Lopes MC, Oliveira-Brett AM (2006) Anal Biochem 355:39–49
Acknowledgements
Financial support from Fundação para a Ciência e Tecnologia (FCT), Post-Doctoral Grant SFRH/BPD/71965/2010 (S.C.B. Oliveira), project PTDC/QUI-QUI/098562/2008, POFC-QREN, POPH (co-financed by the European Community Funds FSE e FEDER/COMPETE), CEMUC-R (Research Unit 285), CNPq - Brazil, Post-Doctoral Grant/201487/2011-0 (I.C. Lopes) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in the topical collection in Bioelectroanalysis with guest editors Nicolas Plumeré, Magdalena Gebala, and Wolfgang Schuhmann.
Rights and permissions
About this article
Cite this article
C. Lopes, I., Oliveira, S.C.B. & Oliveira-Brett, A.M. In situ electrochemical evaluation of anticancer drug temozolomide and its metabolites–DNA interaction. Anal Bioanal Chem 405, 3783–3790 (2013). https://doi.org/10.1007/s00216-012-6546-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-012-6546-x